February 29, 2020

February 28, 2020

Subscribe to Latest Legal News and Analysis

February 27, 2020

Subscribe to Latest Legal News and Analysis

February 26, 2020

Subscribe to Latest Legal News and Analysis

Bard Hernia Mesh Cases Leading the Charge to Settlements in Hernia Mesh Litigations

The primary Bard Hernia Mesh state litigation, pending in Rhode Island state court under Judge Gibney, is now set to begin its first bellwether trials that will focus on claims involving the Ventralex patch product, and proceed to trials involving the Composix E/X product. Not to be outdone, and though only designated in August 2018, the Bard Hernia Mesh Multidistrict Litigation (“MDL”) in the United States District Court for the Southern District of Ohio under Judge Sargus, is also steaming along. Plaintiffs and Defendants have narrowed down the initial bellwether pool to six cases – three cases chosen by each side. On January 13, 2020, the parties will submit briefing detailing which cases each party believes should go to trial. Based on that briefing, on January 24, 2020, the Court will select three of those cases for the first bellwether trials. After remaining case specific discovery and motion practice, those cases will go to trial on May 11, 2020; July 13, 2020; and September 14, 2020.

All of this is playing out against the backdrop of the looming Atrium C-QUR Hernia Mesh MDL bellwether cases, in the United States District Court for the District of New Hampshire under Judge McCafferty, moving through similar procedures and set to begin on May 20, 2020. Then there is the Physiomesh Hernia Mesh MDL in the United States District Court for the Northern District of Georgia under Judge Story, with the first bellwether trial scheduled for July 20, 2020, and the related lawsuits currently consolidated in New Jersey state court under Judge Porto following closely behind.

The Plaintiffs hope that the aggressive prosecution of these hernia mesh lawsuits to bellwether trials is likely to lead to quicker, and more favorable, settlements for those injured by the numerous manufacturers of defective hernia mesh.

COPYRIGHT © 2020, STARK & STARK

TRENDING LEGAL ANALYSIS


About this Author

Martin P. Schrama, Stark Law, Intellectual Property and Litigation Law Attorney
Shareholder

Martin P. Schrama is a Shareholder in Stark & Stark's Commercial Litigation, Mass Tort, Intellectual Property and Green Litigation Groups. Mr. Schrama has extensive experience litigating on both the trial and appellate levels of the federal and state courts of New Jersey and New York, as well as numerous other jurisdictions throughout the nation in a pro hac vice capacity. This experience also extends to regular practice before AAA, JAMS and various other alternate dispute resolution fora.

The primary focus of Mr. Schrama’s practice is...

609-895-7334
Stefanie Colella Walsh, Pharmaceutical Litigation Attorney, Stark Law Firm
Shareholder

Stefanie Colella-Walsh is a Shareholder and member of Stark & Stark’s Litigation, Insurance Coverage & Liability, Intellectual Property and Mass Torts Groups where she concentrates her practice in complex litigation with a focus in mass tort and pharmaceutical litigation. She also handles litigation related to nursing home negligence and abuse claims, elder abuse, and assisted living facility litigation.

Recently, Ms. Colella-Walsh was a member of the national trial team involved the first trial in the country of a TVT-Secur transvaginal mesh device case against Ethicon/Johnson and Johnson. 

609-219-7416